Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lamotrigine for Corticosteroid-Induced Cognitive Impairment
NCT00223262Phase 4Completed
- Sponsor
- UT Southwestern Medical Center
- Start
- Aug 2002
- Primary completion
- Sep 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of lamotrigine in corticosteroid-induced cognitive impairment, corticosteroid-induced mood disorder, sponsored by UT Southwestern Medical Center. Started Aug 2002; status: completed.
02
Drugs
lamotrigine
03
Conditions
corticosteroid-induced cognitive impairmentcorticosteroid-induced mood disorder
Beyond the preview
Go deeper on NCT00223262.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00223262.